Last updated on May 2019

BAX 855 Previously Untreated Patient (PUP)


Brief description of study

The purpose of this study is to investigate safety, immunogenicity and hemostatic efficacy of PEGylated recombinant FVIII (BAX 855) in previously untreated patients (PUPs) < 6 years of age with severe hemophilia A (baseline FVIII level < 1%) and < 3 EDs to ADVATE, BAX 855 or plasma transfusion.

Clinical Study Identifier: NCT02615691

Find a site near you

Start Over

Phoenix Childrens Hospital

Phoenix, AZ United States
  Connect »

University of California

Sacramento, CA United States
  Connect »

Univ Florida College Medicine

Gainesville, FL United States
  Connect »

Emory University

Atlanta, GA United States
  Connect »

The Presbyterian Hospital

Charlotte, NC United States
  Connect »

Cincinnati Children's Hospital

Cincinnati, OH United States
  Connect »

Rainbow Babies/Childrens Htl

Cleveland, OH United States
  Connect »

Texas Children's Hospital

Houston, TX United States
  Connect »

Primary Children's Medical Center

Salt Lake City, UT United States
  Connect »

HUDERF

Bruxelles, Belgium
  Connect »

CHU de Rouen

ROUEN Cedex, France
  Connect »

Eulji University Hospital

Daejeon, Korea, Republic of
  Connect »

Severance Hospital, Yonsei

Seoul, Korea, Republic of
  Connect »

Ulsan University Hospital

Ulsan, Korea, Republic of
  Connect »

Hospital Kuala Lumpur

Kuala Lumpur, Malaysia
  Connect »

Spitalul Clinic

Targu Mures, Romania
  Connect »

KKH

Singapore, Singapore
  Connect »

Siriraj Hospital

Bangkoknoi, Thailand
  Connect »

Ramathibodi Hospital

Ratchathewi, Thailand
  Connect »

Univ Hospital Southampton

Southampton, United Kingdom
  Connect »

UC Davis Health System

Sacramento, CA United States
  Connect »

UMHS

Ann Arbor, MI United States
  Connect »

Wake Forest Baptist Medical Center

Winston-Salem, NC United States
  Connect »

Primary Children's Hospital

Salt Lake City, UT United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.